BioWorld Asia

May 8, 2002

View Archived Issues

GenOway Enters Drug Target Deal, Plans $5.4M Financing

PARIS - GenOway SA signed a nonexclusive agreement with the French pharmaceutical company Servier for the in vivo validation of a number of therapeutic gene targets. (BioWorld International Read More

EU Advisers Support Stem Cell Research, Cautious On Patents

Read More

Reprogramming Technique Raises Hopes Of Adult Skin Cell Therapy

Read More

Screentec Signals Discovery Ambitions With Name Change

Read More

Other News To Note

Read More

MMI Raises £1.6M In Placement To Finance Start-Ups, Incubators

Read More

Proteome Sciences’ Data Show Sensitivity, Specificity In Test

Read More

Personal Chemistry Purchases ESyTech To Extend Platform

Read More

Cerep Completes Drug Target Validation Under 1999 BMS Deal

Read More